Wha Bin Im

Wha Bin Im

Auto-generated profile, based on publicly available information

Wha Bin Im

BiologyII/Neurobiology, 0216-209-512, Pharmacia, 301 Henrietta Street, Kalamazoo, Michigan 49007, USA

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 1999 in British Journal of Pharmacology
Verified
Journal Article
Closed access
PZPhillip G Zaworski
Phillip G Zaworski
GAGlen L Alberts
Glen L Alberts
JPJeffrey F Pregenzer
Jeffrey F Pregenzer
WIWha Bin Im
Wha Bin Im
JSJerry L Slightom
Jerry L Slightom
GGGurnam S Gill
Gurnam S Gill

1 July 2003 in Molecular Pharmacology
Verified
Journal Article
Closed access
PDF file
WIWha Bin Im
Wha Bin Im
CCChristopher L. Chio
Christopher L. Chio
GAGlen L. Alberts
Glen L. Alberts
DDDac M. Dinh
Dac M. Dinh
The human 5-hydroxytryptamine-2C (5-HT2C) receptor has been the target of potential anxiolytics and antiobesity drugs, and its positive allosteric modulator was discovered to be l-threo-α-d-galacto-octopyranoside, methyl-7-chloro-6,7,8-trideoxy-6-[[(4-undecyl-2-piperidinyl)carbonyl]amino]-1-thiomonohydrochloride (2S-cis) (PNU-69176E). The drug at low micromolar concentrations (<25 μM) markedly enhanced [3H]5-HT binding (more than 300%) by increasing its affinity for low-affinity sites but with no appreciable effect on antagonist ([3H]mesulergine) binding. Functionally, PNU-69176E alone rendered receptors constitutively active, producing the pheno-types of 5-HT–activated receptors, as measured with mesulergine-sensitive guanosine 5′-O-(3-[35S]thio)triphosphate binding, transient inositol 1,4,5-triphosphate release, and [3H]inositol phosphate accumulation. These actions of PNU-69176E were observed with the human 5-HT2C receptor expressed in several mammalian cell lines (human embryonic kidney 293, NIH3T3, and SH-EP) at variable receptor densities (6 to 45 pmol/mg of protein), but not with analogous 5-HT and dopamine receptors (human 5-HT2A, 5-HT2B, 5-HT6, 5-HT7, and dopamine D2-long and D3 receptors). Structurally, PNU-69176E consists of a long alkyl chain and a polar moiety, including the α-d-galactopyranoside. Its analogs with shorter alkyl chains (methyl to n-hexyl instead of n-undecyl group) failed to enhance [3H]5-HT binding, and also long alkyl amides are without allosteric modulation. We propose that PNU-69176E may represent a new class of membrane receptor modulators, which probably need a long alkyl chain as a membrane anchor and target a selective polar head group to receptor modulatory sites near the membrane surface.

1 May 1999 in British Journal of Pharmacology
Verified
Journal Article
Closed access
PDF file
JPJeffrey F Pregenzer
Jeffrey F Pregenzer
GAGlen L Alberts
Glen L Alberts
WIWha Bin Im
Wha Bin Im
JSJerry L Slightom
Jerry L Slightom
MEMichael D Ennis
Michael D Ennis
RTRuth E TenBrink
Ruth E TenBrink

1 October 2000 in British Journal of Pharmacology
Verified
Journal Article
Open access
PDF file
GAGlen L Alberts
Glen L Alberts
JPJeffrey F Pregenzer
Jeffrey F Pregenzer
WIWha Bin Im
Wha Bin Im
The human D2long dopamine receptor when expressed heterologously in a human neuronal cell line, SH‐SY5Y, produced more robust functional signals than when expressed in a human embryonic kidney cell line, HEK293. Quinpirole (agonist)‐induced GTPγ35S binding and high affinity sites were 3–4 fold greater in SH‐SY5Y than in HEK293 cells. N‐type Ca2+ channel currents present in SH‐SY5Y cells, but not HEK293 cells, were inhibited potently by quinpirole with a half‐maximal inhibitory concentration of 0.15±0.03 nM. Inhibition of adenylyl cyclases by agonists, on the other hand, was of similar potency and efficacy in the two cell lines. GTPγ35S‐Bound Gα subunits from quinpirole‐activated and solubilized membranes were monitored upon immobilization with various Gα‐specific antibodies. Gαi and Gαo subunits were highly labelled with GTPγ35S in SH‐SY5Y cells, but only Gαi subunits were labelled in HEK293 cells. The additional Go coupling in SH‐SY5Y cells could arise, at least in part, from the presence of Go coupled‐effectors, such as the N‐type Ca2+ channel, and may contribute to robust agonist‐induced GTPγ35S binding, which is a reliable means for measuring ligand intrinsic efficacy. It appears that expression of neuronal G protein‐coupled receptors in neuronal environments could reveal additional functional characteristics that are absent in non‐neuronal cell lines. This appears to be due to, at least in part, to the presence of neuron‐specific effectors. These findings underscore the importance of the cellular environment in which drug actions are examined, particularly in the face of intensive efforts to develop drugs for G protein‐coupled receptors of various origins. British Journal of Pharmacology (2000) 131, 514–520; doi:10.1038/sj.bjp.0703580

1 February 2003 in British Journal of Pharmacology
Verified
Journal Article
Closed access
PDF file
GAGlen L Alberts
Glen L Alberts
CCChristopher L Chio
Christopher L Chio
WIWha Bin Im
Wha Bin Im
JSJerry L Slightom
Jerry L Slightom